Updates
  • Today - Tuesday, January 15, 2019
  • Nordstrom -2.8% on holiday sales, guidance

    • Nordstrom (NYSE:JWN) is 2.8% lower after hours following its holiday sales report and updated guidance.
    • Comparable sales were up 1.3% for the nine weeks ended Jan. 5, vs. the period ending Jan. 6, 2018.
    • In Full-Price, comp sales rose 0.3% vs. Q3's YTD gain of 1.9%, amid softer store traffic. Off-Price comp sales rose 3.9%, more consistent with the rest of the year.
    • Digital sales were up 18% and made up 36% of sales.
    • YTD comp sales of 2.1% were in line with prior outlook, but Full-Price sales were below expectations, so Nordstrom has incorporated into expectations higher holiday markdowns and to reposition inventory to a more appropriate level by the end of the year.
    • It says EPS should be toward the low end of previous guidance for $3.27-$3.37 (including Q3 nonrecurring charge of $0.28) or $3.55-$3.65 excluding that charge.
    • It's scheduled to report Q4 and full-year results after the close on Feb. 28.
    | 6:12 PM | Comment
  • Mercer +6.6% on index moves; GDOT, TFX changing indexes

    • Mercer International (NASDAQ:MERC) is up 6.6% after hours following the latest index musical chairs: It's heading into the S&P SmallCap 600.
    • It's going there to replace Green Dot (NYSE:GDOT), which is moving up to the MidCap 400. GDOT is up 0.1% after hours.
    • And Green Dot is making its move to replace MidCap 400 constituent Teleflx (NYSE:TFX), which is moving into the S&P 500. TFX is down 0.4% postmarket.
    • Teleflex will replace PG&E, which is expecting to file for Chapter 11 and isn't eligible to remain in the S&P 500.
    | 5:39 PM
  • UAL, HL and CDE among notable after hour movers

    | 5:36 PM
  • Snap -4.9% as CFO resigns

    • Snap (NYSE:SNAP) is off 4.9% postmarket after an SEC filing shows that Chief Financial Officer Tim Stone told the company he'd resign to pursue other opportunities.
    • The exit isn't related to "any disagreement with us on any matter relating to our accounting, strategy, management, operations, policies, regulatory matters, or practices (financial or otherwise)," the company says.
    • His last day is undetermined and he'll serve in the meantime to help search for a replacement and effect a smooth transition, "including through our scheduled full year 2018 financial results announcement."
    • In the same filing, the company says that while it's finalizing its Q4 results, it expects to report revenue and adjusted EBITDA that are "slightly favorable to the top end" of previously reported guidance.
    | 5:28 PM | 27 Comments
  • Fulton drops 9.0% after Q4 miss

    • Fulton Financial (NASDAQ:FULTsinks 9.0% in after-hours trading after Q4 EPS of 33 cents falls short of consensus by 2 cents.
    • Compares with 37 cents in Q3 and 19 cents in the year-ago quarter.
    • Q4 net interest income rose to $162.9M from $160.1Min Q3 and $149.4M in Q4 2017.
    • Q4 net interest margin of 3.44% compares with 3.42% in Q3 and 3.29% in the year-ago quarter.
    • Q4 net charge-off to average loans increased to 0.17% annualized from 0.08% in Q3 and 0.14% in Q4 2017.
    • Effective income tax rate was 8.6% vs. 11.5%% in Q3.
    • Separately, Fulton announces that the state of Maryland and the FDIC terminates consent orders relating to Fulton's Columbia Bank subsidiary.
    • Previously: Fulton Financial misses by $0.02, misses on revenue (Jan. 15)
    | 5:16 PM
  • United Continental +5% after posting strong quarter

    • United Continental (NASDAQ:UAL) rallies after topping estimates with its Q4 report.
    • Unit revenue was up 5% Y/Y during the quarter to fall on the top of United's guidance range. Cost per available seat mile rose 7% Y/Y.
    • The company also reported an adjusted pre-tax margin of 7.8% vs. 6.9% a year ago.
    • Load factor +100 bps to 82.7%.
    • Looking ahead, United expects FY19 EPS of $10.00 to $12.00 vs. $10.98 consensus.
    • UAL +5.4% AH to $85.65
    • Previously: United Continental beats by $0.45, beats on revenue (Jan. 15)
    | 4:34 PM
  • Hanmi sinks 8.5% after Q4 miss

    • Hanmi Financial (NASDAQ:HAFCplunges 8.5% in after-hours trading Q4 EPS of 37 cents, which includes 9 cents of charges related to tax items.
    • Excluding the one-time tax items, Hanmi earned 46 cents per share in the quarter compared with consensus estimate of 51 cents.
    • Compares with 50 cents in Q3 and 36 cents in the year-ago quarter.
    • “Our results in the fourth quarter reflect our strategic decision to moderate loan growth, protect net interest margin and reduce expenses given the increasingly challenging banking environment," says CEO C.G. Kum.
    • Q4 net interest income of $45.6M slips 0.7% Q/Q and down 1.5% Y/Y.
    • Q4 net interest margin of 3.51% rose from 3.48% in Q3 and fell from 3.79% in Q4 2017.
    • Return on average stockholders' equity of 7.92% retreats from 10.91% in Q3 and 8.12% in the year-ago quarter.
    • Conference call at 5:00 PM ET.
    • Previously: Hanmi Financial misses by $0.14, beats on revenue (Jan. 15)
    | 4:32 PM
  • EFI reports downside preliminary guidance

    • Electronics For Imaging (NASDAQ:EFII) reports preliminary Q4 results with revenue of $255M to $257M (consensus: $280.7M) and EPS of $0.45 to $0.47.
    • Cash flow from operating activities is expected to be $30M to $33M.
    • EFII says the results were "impacted by weakening economic conditions experienced across its direct businesses, with customers delaying spend on capital equipment and software."
    • The company will hold a conference call at 5 PM ET today to discuss the preliminary results with a webcast available here.
    • EFII shares were halted ahead of the news.
    • Update: EFII resumes trading down 10% to $24.48.
    | 4:28 PM | Comment
  • Revance readies stock offering

    • Revance Therapeutics (NASDAQ:RVNC) initiates a $100M public stock offering. Price, volume and terms have yet to be announced.
    | 4:21 PM
  • United Continental beats by $0.45, beats on revenue

    • United Continental (NASDAQ:UAL): Q4 Non-GAAP EPS of $2.41 beats by $0.45; GAAP EPS of $1.70 misses by $0.17.
    • Revenue of $10.49B (+11.0% Y/Y) beats by $130M.
    • Shares +3%.
    • Press Release
    | 4:18 PM | Comments
  • Inphi +5% on Q1 guidance

    • Inphi (NYSE:IPHIgains 5.2% after CEO Ford Tamer speaks at the Needham Growth Conference and guides mid-30s percent revenue growth Y/Y in the first quarter compared to the 36% consensus estimate.
    • Inphi reports earnings on January 29.
    • Source: Bloomberg First Word.
    | 3:46 PM | Comment
  • British pound erases day's loss after Brexit vote

    • British pound erases its earlier loss and strengthens 0.2% against the dollar in late afternoon in U.S. ET after Theresa May's Brexit plan is overwhelmingly rejected by Parliament.
    • Before the vote, the pound had weakened as much as 1.5% against the dollar.
    • iShares MSCI United Kingdom (NYSEARCA:EWU+0.4%; had been down as much as 0.7% earlier.
    • Previously: May's government to face no-confidence vote (Jan. 15)
    • ETFs: FXB, EWU, OTC:GBB, DBUK, FKUHEWU, QGBR, DGBP, FLGB, UGBP
    | 3:45 PM
  • Bel provides Q418 update

    • Bel Fuse Inc (BELFA) expects Q4 revenue of $143M (+19% Y/Y) vs. a consensus of $136M.
    • Full year 2018 sales of ~$548M (+11.5% Y/Y) vs. a consensus of $541.5M.
    • Annual bookings for 2018 to ~$578M as compared to $516M in 2017.
    • The Company’s backlog of orders was $171.2M (+17% Y/Y) at Dec 31, 2018.
    • The Company expects to report its preliminary financial results on Feb. 21, 2019.
    | 3:39 PM
  • Avalon Globocare files for $50M mixed shelf offering

    | 3:38 PM
  • Tilray under pressure on expiration of lockup period, down 18%

    • Cannabis producer Tilray (TLRY -17.8%) is down on almost a 5x surge in volume approaching the end of the session. The lockup period expired today. Although top shareholder Privateer Holdings stated that it was holding on to its 76% stake (~75M shares), about 8M were expected to be released today.
    • The company debuted on Nasdaq on July 15, 2018.
    | 3:35 PM | 15 Comments
  • AG nominee Barr won't "go after" pot companies

    | 3:24 PM | 35 Comments
  • Goodyear Tire & Rubber sinks to 52-week low

    • Shares of Goodyear Tire & Rubber (GT -14.2%) plunge after the company ran through a litany of issues that held back Q4 tire volume.
    • Issues impacting demand were seen in China, Europe, India and the U.S., according to execs presenting at an investor conference.
    • Goodyear traded at a 52-week low of $18.67 minutes ago.
    • Previously: Goodyear Tire & Rubber -3% after disclosing volume drop (Jan. 15)
    | 3:22 PM | Comment
  • Alio Gold eyes rising production for Florida Canyon mine

    • Alio Gold (ALO -4.7%) says its updated life-of-mine plan for the Florida Canyon Mine in Nevada forecasts total gold production of 734K oz. over a 9.8-year mine life.
    • ALO says its plan shows total proven and probable mineral reserves of 1.01M oz. of gold based on a pit designed to maximize project economics at $1,250/oz. gold.
    • Florida Canyon produced 47.4K oz. of gold in 2018, and the company expects the mine to produce ~60K oz. in 2019 at a cash cost of ~$1K/oz. before averaging 75K oz. annually for the next eight years.
    • ALO says it will evaluate opportunities to enhance the value of Florida Canyon in 2019 including the restart of the adjacent Standard Mine and the strategic value of the sulfide deposit underlying the oxide reserves.
    | 3:10 PM | Comment
  • Microcaps dominate tech movers

    • Gainers: VirnetX Holding (NYSEMKT:VHC) +53%. Sonic Foundry (OTC:SOFO) +34%. BSQUARE Corporation (NASDAQ:BSQR) +32%. Resonant (NASDAQ:RESN) +29%. FTE Networks (NYSEMKT:FTNW) +13%.
    • Losers: Internet Gold - Golden Lines (NASDAQ:IGLD) -19%. Maxar Technologies (NYSE:MAXR) -12%. Sphere 3D (NASDAQ:ANY) -11%. Aehr Test Systems (NASDAQ:AEHR) -10%. OptimizeRx (NASDAQ:OPRX) -8%.
    | 3:00 PM
  • Chipotle at ICR: More TV ads, testing on new menu items

    • Chipotle (CMG +1.9%) is allocating more money to TV advertisements and social media engagement, according to execs today speaking at the ICR conference.
    • "The brand just became invisible. And we are working to make it more visible," sums up CEO Brian Niccol on the strategy.
    • On the topic of menu innovation, Chipotle revealed at ICR that nachos, tostadas and chocolate shakes are all in testing phase. Still, the company plans to take a cautious approach before commiting to any national rollouts for the products.
    • Shares of Chipotle are starting 2019 on an upswing, up 19% YTD already including today's rally.
    | 2:52 PM | Comment
  • Edison cut to Sell at BAML on California's 'challenging operating environment'

    • Edison International (EIX -5.6%) is downgraded to Underperform from Neutral with a $61 price target, trimmed from $64, at BofA Merrill Lynch, which cites the challenging operating environment in California following the PG&E Chapter 11 filing.
    • BAML analyst Julien Dumoulin-Smith says shares are not "investable" until there is clear legislation that limits inverse condemnation and related liabilities.
    • "Bankruptcy is PG&E’s response to the risk" of inverse condemnation, says Severin Borenstein of the Energy Institute at the Haas School of Business at Cal-Berkeley. "That leads to the larger question of whether or not this bankruptcy leads to... how we have utilities in California, and if we move from private firms to government owned."
    • EIX shares have fallen ~20% since Nov. 8, when the northern California fires began to take down PG&E.
    | 2:46 PM | Comments
  • PG&E misses interest payment on 2040 notes

    • Nearly all of PG&E's (PCG -19.7%) $18B in bonds trade lower after the company failed to make a $21.6M interest payment due today on its 2040 senior notes.
    • In response to a request for comment, the company notes the "30-day grace period to make the interest payment before triggering an event of default."
    • The price of the 2040 bond, which is worth $800M and has a 5.4% coupon rate, is 4.75 points lower today with its yield spread vs. U.S. Treasury securities rising by 4.77 percentage points.
    | 2:28 PM | Comments
  • IHS Markit +2.5% after double-digit revenue gains

    • IHS Markit (NASDAQ:INFO) is up 2.5% today after topping profit expectations with double-digit revenue gains in Q4.
    • Gains in Transportation and Financial Services paced an overall 13% gain in revenues, which fell a hair short of consensus.
    • On an organic basis, revenues rose 5%.
    • Cash flow from operations came in at $358M; free cash flow was $303M.
    • Revenue by segment: Resources, $223M (up 3%); Transportation, $297M (up 11%); Consolidated Markets & Solutions, $139M (down 1%); Financial Services, $409M (up 27%).
    • For the coming year, it's guiding to revenues of $4.425B-$4.5B (vs. consensus for $4.48B); that includes organic growth of 5-6% (including Ipreo for a four-month stub period) or 6-7% (including Ipreo for the full 12 months).
    • It also sees EBITDA of $1.75B-$1.78B and EPS of $2.52-$2.57 (vs. consensus for $2.56).
    • Earnings call slides
    • Previously: IHS Markit beats by $0.02, misses on revenue (Jan. 15 2019)
    • Press release
    | 2:18 PM
  • PetIQ soars after ICR presentation

    • PetIQ (PETQ +13.1%) soars after the company says during its ICR presentation that it aims to double annual sales to over $1B in the long term.
    • PetIQ is also targeting 25% EPS growth.
    • PetIQ conference presentation webcast
    | 2:18 PM
  • Tenable +12.7% as Morgan Stanley leaves sidelines

    • Tenable (TENB +12.5%gains 12.7% after Morgan Stanley upgrades the company from Equal-Weight to Overweight and raises the target by a dollar to $31.
    • The firm names Tenable among its "secularly attractive security names now trading at a meaningful discount to growth."
    • Source: Bloomberg First Word.
    | 2:17 PM | Comment
  • Valhi and Aceto among Energy/Materials gainers; Legacy Reserves and PEDEVCO among losers

    • Gainers: Valhi (NYSE:VHI) +23%. Aceto (NASDAQ:ACET) +19%. Quintana Energy Services (NYSE:QES) +8%. Superior Drilling Products (NYSEMKT:SDPI) +8%. Ossen Innovation (NASDAQ:OSN) +6%.
    • Losers: Legacy Reserves (NASDAQ:LGCY) -13%. PEDEVCO (NYSEMKT:PED) -12%. First Majestic Silver (NYSE:AG) -10%. Coeur Mining (NYSE:CDE) -8%. Venator Materials (NYSE:VNTR) -7%.
    | 1:59 PM
  • Bristol-Myers gets two-notch upgrade post-Celgene deal

    • ScoGen was previously the only sell-side shop with a Sell rating on Bristol-Myers Squibb (NYSE:BMY), but is a big fan of the Celgene (NASDAQ:CELG) acquisition, and upgrades all the way to Buy.
    • The team figures the purchase will add $17 per share to BMY's stock price (which currently sits just south of $50), and estimates there's an 80% chance of the deal closing.
    • Shares are up 2.8% today.
    • Source: Bloomberg
    | 1:28 PM | 15 Comments
  • 360 Finance leads financial gainers; Maiden Holdings and LM Funding America the only losers

    • Gainers: 360 Finance (NASDAQ:QFIN) +26%. The RMR Group (NASDAQ:RMR) +15%. First Republic Bank (NYSE:FRC) +12%. Hexindai (NASDAQ:HX) +7%. Fanhua (NASDAQ:FANH) +5%.
    • Losers: Maiden Holdings (NASDAQ:MHLD) -8%. LM Funding America (NASDAQ:LMFA) -7%.
    | 12:56 PM
  • VHC, MBOT, PCG and CHFS among midday movers

    • Gainers: Kitov Pharma (NASDAQ:KTOV) +159%. Microbot Medical (NASDAQ:MBOT) +81%. Blue Apron Holdings (NYSE:APRN) +38%. VirnetX Holding (NYSEMKT:VHC) +35%. BSQUARE Corporation (NASDAQ:BSQR) +32%. Tyme Technologies (NASDAQ:TYME) +29%. Resonant (NASDAQ:RESN) +28%. CHF Solutions (NASDAQ:CHFS) +23%. 360 Finance (NASDAQ:QFIN) +23%. Valhi (NYSE:VHI) +21%.
    • Losers: Estre Ambiental (NASDAQ:ESTR) -35%. PG&E Corporation (NYSE:PCG) -21%. Biocept (NASDAQ:BIOC) -19%. Internet Gold - Golden Lines (NASDAQ:IGLD) -19%. Future FinTech Group (NASDAQ:FTFT) -17%. Stellar Biotechnologies, Inc. (NASDAQ:SBOT) -14%. Constellation Pharmaceuticals (NASDAQ:CNST) -12%. Co-Diagnostics (NASDAQ:CODX) -12%. Tilray (NASDAQ:TLRY) -11%. Sphere 3D (NASDAQ:ANY) -11%.
    | 12:43 PM
  • Analysts back Netflix pricing action

    • Piper Jaffray is out of the gate with a positive note on the prices hikes at Netflix (NFLX +6.9%).
    • Surveys indicate Netflix has plenty of pricing flexbility with customers before churn is a significant issue, according to the firm.
    • RBC Capital Markets analyst Mark Mahaney sees a $1B incremental boost to the top line from the price increase in the U.S. Mahaney thinks a good portion of the extra revenue will go toward meeting content obligations, but some amount will make its way down to Netflix's bottom line.
    • SunTrust analyst Matthew Thornton says the pricing action from Netflix makes sense with the upcoming content slate from the streamer very strong.
    • Previously: Netflix +5% on report of price hikes (Jan. 15)
    | 12:41 PM | 21 Comments
  • Investors slam $8M payout due Goldcorp CEO from Newmont deal

    • A group of gold investors including John Paulson criticizes Newmont Mining’s (NEM -2.3%) planned $10B acquisition of Goldcorp (GG -1.8%) and the ~$8M reward due CEO David Garofalo from the deal.
    • The Shareholders’ Gold Council, formed last year to promote the interests of gold investors, said Garofalo had been “massively overpaid” since his appointment in 2016 - more than $16M in 2016-17 combined - while shares have fallen by 26% under the CEO; now Garofalo stands to reap another $8M due to change of control provisions in his contract.
    • “While Garofalo has been massively overpaid, stockholders have lost over C$3.7B since his appointment, and Goldcorp now wants to sell itself at only a slight premium to its one-, three-, five-, seven- and 10-year low in share price,” the Shareholders’ Gold Council says.
    • NEM CEO Gary Goldberg is expected to remain in his position to close the acquisition, then COO Tom Palmer will take over; it is not yet clear whether Garofalo will stay on at the combined company following the deal.
    | 12:21 PM | 20 Comments
  • FDA tags three Cerecor candidates Orphan Drugs; shares up 2%

    • The FDA designates the following Cerecor (CERC +2.1%) candidates Orphan Drugs:
    • D-galactose for phosphoglucomutase 1 deficiency.
    • D-mannose for mannose phosphate isomerase deficiency.
    • L-fucose for congenital disorder of glycosylation IIc.
    • Among the benefits of Orphan Drug status in the U.S. is a seven-year period of market exclusivity for the indication, if approved.
    | 12:16 PM
  • PetIQ outlook lifts shares, up 11%

    • PetIQ (PETQ +10.6%) is up on below-average volume following its presentation at the ICR Conference in Orlando, FL. Highlights:
    • Plans to build 1,000 new clinics by 2023. Rollout of first 34 just completed.
    • FY2018 sales should be ~$515M (in line with consensus). Non-GAAP EBITDA should be $40M - 45M.
    • Long-term targets: 15% annual sales growth; 15% non-GAAP EBITDA margin by 2023; annual non-GAAP EBITDA growth: 20%; EPS growth: 25%.
    | 12:07 PM | Comment
  • Reed's leads consumer gainers; Westport Fuel Systems and Vuzix among losers

    • Gainers: Reed's (NYSEMKT:REED+15%. Truett-Hurst (NASDAQ:THST) +14%. American Axle & Manufacturing (NYSE:AXL) +8%. Summer Infant (NASDAQ:SUMR) +7%. Primo Water (NASDAQ:PRMW+7%
    • Losers: Future FinTech Group (NASDAQ:FTFT) -17%. Westport Fuel Systems (NASDAQ:WPRT) -7%. Cooper-Standard Holdings (NYSE:CPS) -6%. Dogness International (NASDAQ:DOGZ-6%. Vuzix (NASDAQ:VUZI) -5%.
    | 12:06 PM
  • Facebook investing $300M for local news survival

    • Facebook (FB +3.2%) plans to invest $300M in local news over the next three years, a defense against flak that it's damaging the business.
    • The difference from prior investments is that this one isn't tied to Facebook-related products.
    • “We’re going to continue fighting fake news, misinformation, and low quality news on Facebook,” says Facebook's Campbell Brown “But we also have an opportunity, and a responsibility, to help local news organizations grow and thrive.”
    • An early round of the investments (going to recipients like the Pulitzer Center and Report for America) will focus on boosting local reporting resources, improving newsgathering through tech, adding "trainee community journalists" and funding a program modeled after the Peace Corps.
    • Previously: Buy Facebook ahead of earnings - Barclays (Jan. 15 2019)
    | 12:04 PM | 41 Comments
  • Citigroup surges 4.1% as BMO upgrades to outperform

    • Citigroup (NYSE:Cjumps 4.1% after BMO Capital analyst James Fotherington upgrades the stock to outperform, saying the bank's Q4 results and outlook were "just fine."
    • Sees three potential upside catalysts: Access to more capital as CCAR nears; Q1 is typically its strongest quarter; benefits from a weakening dollar.
    • Source: The Fly.
    • In midday trading, Citi's intraday high of $61.40 is its highest level since Dec. 4.
    • Analyst ratings: 20 buys, 7 holds, 1 underperform/sell; Analyst earnings estimates.
    • Previously: Citi perks up as volatility moderates (Jan. 14)
    | 11:56 AM | Comments
  • Goodyear Tire & Rubber -3% after disclosing volume drop

    • Goodyear Tire & Rubber (GT -3.3%) drops after the company discloses that Q4 tire unit volume fell 3% vs. a prior forecast of flat growth.
    • The company cites continued weakening of the original equipment environment in China and India and notes the EMEA winter market declined late in the quarter. U.S. supply issues also led to an unfavorable mix shift during the quarter.
    • Goodyear conference presentation slides
    | 11:46 AM | Comments
  • Apollo near deal to buy Arconic for $10B-plus - WSJ

    • Arconic (ARNC +3.9%) spikes higher after WSJ reports Apollo Global Management (APO +2%) is near a deal to buy the company for more than $10B.
    • APO would pay $21-$22/share in a deal that likely will be announced this week, according to the report.
    • If a deal is finalized, it would end a months-long sales process for ARNC, which had a market value of ~$9.3B this morning.
    | 11:40 AM | 38 Comments
  • Euro slips amid dimmer eurozone outlook

    | 11:33 AM
  • Nymox up 3% on article supporting efficacy of lead drug

    • Thinly traded micro cap Nymox Pharmaceutical (NYMX +3.3%) is up on average volume in apparent response to an article published in Therapeutic Advances in Urology supporting the value proposition of lead candidate fexapotide triflutate (FT) in men with benign prostatic hyperplasia (BPH) (enlarged prostate).
    • Based on results from more than 1,700 patients, FT showed long-term effects in improving BPH symptoms while demonstrating an excellent safety profile.
    • Fexapotide triflutate (NX-1207) is a pro-apoptotic (promotes cell death) protein administered directly into the prostate via a transrectal injection that does not require anesthesia or sedation.
    • Marketing applications are being prepared in the U.S. and Europe.
    | 11:21 AM
  • Stratasys +6% on "Fast Money" mention

    • Stratasys (NASDAQ:SSYS) gains after a positive mention on CNBC's "Fast Money" with Dan Nathan recommending the company as a buy.
    • SSYS is up 6.3% while rival 3D Systems (NYSE:DDDgains 2.9%.
    | 11:20 AM | Comments
  • Bank stocks slump amid more disappointing earnings

    • Bank stocks wilt after disappointing earnings from Wells Fargo (WFC -2.5%) and JPMorgan (JPM -0.9%) show that Citigroup's revenue miss yesterday wasn't an outlier.
    • Wells Fargo, struggling from a string of scandals that started in 2016, reported Q4 revenue of $21.0B, missing consensus estimate of $21.8B.
    • JPMorgan's Q4 EPS missed by 23 cents and revenue also fell short of consensus as Markets & Investor Services revenue--which includes fixed-income trading results--fell 29% from Q3 and 11% from a year ago.
    • Other banks falling: Goldman Sachs (GS -0.5%), Bank of America (BAC -0.4%), Morgan Stanley (MS +0.1%).
    • Citigroup (C +3.4%) gains after BMO Capital upgrades the stock to outperform from market perform.
    • Regional banks are also in the red: Fifth Third (FITB -1.2%), KeyCorp (KEY -1%), Comerica (CMA -0.8%), PNC Financial (PNC -0.9%), and Regions Financial (RF -0.6%) are among the biggest decliners.
    • Previously: JPMorgan -1.8% after big Q4 EPS miss (Jan. 15)
    | 11:10 AM | 25 Comments
  • Microbot Medical and CHF Solutions among healthcare gainers; Stellar Biotechnologies and Biocept among losers

    • Gainers: Kitov Pharma (NASDAQ:KTOV) +125%. Microbot Medical (NASDAQ:MBOT) +86%. CHF Solutions (NASDAQ:CHFS) +23%. Achieve Life Sciences (NASDAQ:ACHV) +19%. Tyme Technologies (NASDAQ:TYME) +19%.
    • Losers: Stellar Biotechnologies (NASDAQ:SBOT) -12%. Biocept (NASDAQ:BIOC) -12%. Tilray (NASDAQ:TLRY) -11%. Co-Diagnostics (NASDAQ:CODX) -9%. Verona Pharma (NASDAQ:VRNA) -7%.
    | 11:02 AM
  • U.S. airlines start to feel goverment shutdown impact

    • Delta Air Lines (DAL -0.1%) is the first major airline to report earnings this year and give a glimpse on the impact of the U.S. government shutdown on the sector.
    • The company cited a $25M hit to revenue in Q1, which works out to about a 25 bp cut to unit revenue.
    • Bank of America Merrill Lynch is out with analysis on the Delta update. "While the shutdown should eventually be resolved and the impact be one-time in nature, the near term impact could prove more meaningful than the $25M cited, increasing the near term revenue risk to DAL and other carriers," warns the BAML analyst team.
    • Watch for more updates on the government shutdown from Mesa Air (MESA +1.5%), American Airlines (AAL +0.9%), United Continental (UAL +1.5%), Spirit Airlines (SAVE), Southwest Airlines (LUV +1.3%), Hawaiian Holding (HA +1.1%), Alaska Air GRoup (ALK +0.2%), SkyWest (SKYW -0.9%) and Allegiant Travel (ALGT -1%) as earnings season rolls along.
    | 10:49 AM | 16 Comments
  • Stock gains retreat after China trade comments

    • Major U.S. stock averages slip after U.S. Trade Representative Robert Lighthizer reports little progress in last week's talks with China last week, according to CNBC.
    • He says negotiators didn't make much headway in resolving structural issues and intellectual property protections.
    • The Dow's gain at 0.1% slips from an early 0.5% increase. S&P +0.4%, had been up as much as 0.9%. Nasdaq +1.1%, retreated the least--it had been up as much as 1.4%.
    • Oil jumps 2.4% to $51.71/bbl.
    • Dollar index rises 0.3% to 95.83.
    • 10-year Treasury yield up half a basis point to 2.709%.
    | 10:42 AM | 33 Comments
  • VirnetX +30% as court upholds Apple award

    • A U.S. appeals court upholds the $440M judgement VirnetX won against Apple (AAPL +1%) in a patent infringement case.
    • Apple was appealing the 2016 jury verdict.
    • An administrative court ruled the same patents invalid, but VirnetX is appealing.
    • VHC is up 30% to $5.04.
    | 10:31 AM | 18 Comments
  • Vermillion up 34% on Cigna coverage of OVA1

    • Thinly traded nano cap Vermillion (VRML +33.9%) is up on almost a 5x surge in volume following its announcement that Cigna added ovarian cancer test OVA1 to its preferred coverage list today.
    | 10:27 AM
  • Variety: Spotify India launch could come this month

    • Spotify (SPOT +3.2%) could make a long-awaited debut in India as soon as the end of this month, Variety reports.
    • That was thought to depend on Spotify locking down India deals with the major-label giants Sony, Universal and Warner, but it's possible that Spotify could go forward without them, according to the report.
    • And it's rumored that a launch party is already set for Mumbai on Jan. 31.
    • The company still needs additional deals with labels specializing in various regional languages; Spotify's app will be available in English but it expects to provide music in languages likely including Punjabi, Tamil, Telugu, Malayalam and Bengali.
    | 10:26 AM
  • PG&E plunges another 29% to ~$6/share

    • PG&E (PCG -28.9%) opens with another sharp drop, triggering a circuit breaker halt; shares have now lost nearly two-thirds of their market value since the company declared its intention to file for Chapter 11 bankruptcy.
    • Gov. Newsom and other California lawmakers appear to show little interest in bailing out the company.
    • PG&E’s move “underscores the reality that the state cannot regulate utilities as we have for the last 100 years,” says Betty Yee, the state’s controller.
    • The stock receives two additional downgrades, from Macquarie and Argus Research, which had previously rated PCG a Buy; entering this week, Argus, BAML, Citi, Deutsche Bank, Evercore ISI, J.P. Morgan, Macquarie and Wells Fargo had continued to rate the stock a Buy.
    | 10:23 AM | 74 Comments
  • Veeco Systems +1.5% on Q4 guide

    • Veeco Systems (NASDAQ:VECO) will present at the Needham Growth Conference today and released its investor presentation including Q4 guidance with revenue from $85M to $105M (consensus: $95.9M) with EPS of ($0.25) to ($0.09) (consensus: ($0.16)) at the midpoint.
    • Watch Veeco's conference presentation today at 3:30 PM ET here.
    • Veeco shares are up 1.5% to $8.30.
    | 10:20 AM
  • Cars.com traffic at all-time high

    • Cars.com (CARS +1.7%) announced today twelve consecutive months of traffic gains, up 11% (y/y) in 2018, and a record-breaking month for the company, with a 21% (y/y) increase in Dec. traffic.
    • The company also noted a increase of 8% (y/y) in visits to its mobile app in Dec. 2018.
    | 10:09 AM | Comment
  • Kitov up 60% on encouraging NT219 data

    • Thinly traded nano cap Kitov Pharma (KTOV +59.6%) is up on a healthy 36x surge in volume in response to encouraging preclinical data on cancer candidate NT219, a novel small molecule cancer drug that fights cancer by activating the "OFF" switch in major oncogenic pathways.
    • Collaborators at Hebrew University showed that NT219 binds directly to two known modulators of tumor survival, metastasis and drug resistance. The data also showed that short exposure of cancer cells to NT219 triggered irreversible shutdown of these pathways, producing a long-term anti-cancer effect.
    | 10:07 AM | Comments
  • Device makers in the green after BSX and EW settle patent fights

    • Boston Scientific and Edwards Lifesciences are leading device firms in early trade after agreeing to settle their patent disputes.
    • Selected tickers: (GMED +1%)(NVRO +1.6%)(ISRG +2%)(ZBH +0.9%)(SYK +1.3%)(RMD +1.4%)(PODD +0.9%)(TNDM +0.4%)(DXCM +0.8%)(BIO +0.1%)(BAX +0.9%)(ANGO +1%)(MDT +1.3%)
    | 9:51 AM | Comments
  • Boston Sci and Edwards rally after resolution of patient disputes

    • Boston Scientific (BSX +3.4%) and Edwards Lifesciences (EW +6%) are both up in early trade after settling their global patent rows.
    | 9:45 AM | Comments
  • Micron FCF sustainable, says Wells Fargo

    • Wells Fargo analyst Aaron Rakers says Micron (MU +0.8%) can sustain positive FCF at downturn levels similar to 2009.
    • Rakers' comments follow a meeting with Micron's CFO. The analyst says concerns over the first quarter inventory build are driven by NAND versus DRAM inventory, but Micron is comfortable it can manage inventory normalization.
    • The firm lowers its Micron 2019 and 2020 EPS and revenue estimates.
    • Source: Bloomberg First Word.
    | 9:42 AM | 63 Comments
  • Netflix +5% on report of price hikes

    • Netflix (NASDAQ:NFLX) is hiking prices by 13% to 18%, according to Associated Press.
    • AP's Michael Liedtje says the increase is the largest by the company in 12 years.
    • The price increases in the U.S. include a bump on the most popular plan to $13 per month from $11 and an increase in the premium ultra-high def service to $16 from $14.
    • Shares of Netflix are up 5.13% in premarket trading to $350.00.
    | 9:24 AM | 194 Comments
  • Microbot down 3% premarket on stock offering

    • Nano cap Microbot Medical (NASDAQ:MBOT) slips 3% premarket on robust volume in response to its direct offering of 455,323 common shares at $6.50 per share to an institutional investor, a discount of 34% from yesterday's close of $9.79, despite the company regarding the offering as "at-the-market."
    • Update: The company announced that it inked deals with several institutional investors for the purchase of 590K shares at $10 per share.
    | 9:18 AM | Comment
  • SSYS, ARRY among premarket gainers

    • Kitov Pharma (NASDAQ:KTOV) +60% on new findings from its ongoing collaboration with researchers from the Hebrew University  of Jerusalem revealing NT219’s high affinity and selective binding to its target proteins.
    • Ability (NASDAQ:ABIL) +27%.
    • Safe-T Group (NASDAQ:SFET) +18% on joining the Symantec Technology Integration Partner Program.
    • Blue Apron Holdings (NYSE:APRN) +8% after update.
    • New Age Beverages (NASDAQ:NBEV) +6%.
    • TransEnterix (NYSEMKT:TRXC) +6% on FDA clearance for senhance ultrasonic system.
    • Stratasys (NASDAQ:SSYS) +6%.
    • Achieve Life Sciences (NASDAQ:ACHV) +6%.
    • SAExploration Holdings (NASDAQ:SAEX) +6%.
    • Array BioPharma (NASDAQ:ARRY) +5% on analyst upgrade and on positive late-stage data on triplet therapy for certain type of colorectal cancer.
    | 9:16 AM | Comment
  • AMD +1% on rumors of Intel interest

    • AMD (NASDAQ:AMD) and Intel (NASDAQ:INTC) gain after an EE Times report of a CES rumor that Intel is considering acquiring AMD.
    • Analysts dismiss the idea outright and say the FTC would never allow the deal.
    • AMD shares are up 1.4% premarket to $20.52.
    • INTC is up 0.1% to $48.41.
    | 9:15 AM | 106 Comments
  • SHW, BIOC and ALNY among premarket losers

    • Biocept (NASDAQ:BIOC) -20%.
    • PG&E (NYSE:PCG-19%.
    • Stellar Biotechnologies (NASDAQ:SBOT) -8%.
    • Alnylam Pharmaceuticals (NASDAQ:ALNY-7% on pricing common stock offering.
    • The Sherwin-Williams (NYSE:SHW-5% after soft guidance update.
    | 9:10 AM
  • Aytu Bio launches new cough medicine in U.S., shares up 29% premarket

    • Nano cap Aytu BioScience (NASDAQ:AYTU) is up 29% premarket on increased volume following its announced U.S. launch of Tuzistra XR, a 12-hour codeine-based cough suppressant.
    • The company in-licensed the product from Tris Pharma about two months ago.
    | 9:08 AM
  • Albemarle, Livent downgraded at Nomura on price data point outlook

    • Albemarle (NYSE:ALB) -1.8% pre-market after Nomura downgrades the stock and lithium producing peer Livent (NYSE:LTHM) to Neutral from Buy, expecting "price data points to surprise negatively in coming months... [which] could drive ALB and LTHM trading multiples lower."
    • Nomura analyst Aleksey Yefremov cuts his stock price target for ALB to $85 from $90 while maintaining his LTHM price target at $16.
    • But with more stable pricing than peers, Nomura still views ALB and LTHM as more attractive than the broader lithium industry.
    | 9:06 AM | Comments
  • FDA Ad Com approaches for Sanofi and Lexicon's sotagliflozin

    • The FDA's Endocrinologic and Metabolic Drugs Advisory Committee will meet on Thursday, January 17, to review and discuss Sanofi's (NASDAQ:SNY) marketing application seeking approval for orally administered sotagliflozin as an adjunct to insulin to improve glycemic control in adults with type 1 diabetes.
    • Shares are up 1% premarket while co-development partner Lexicon Pharmaceuticals (NASDAQ:LXRX) is up 2%.
    • FDA briefing doc
    • Errata to FDA briefing doc
    • Sanofi briefing doc 
    | 8:45 AM
  • Wells Fargo Q4 reflects loan growth, lower taxes

    • Wells Fargo (NYSE:WFC) Q4 EPS of $1.21 beats consensus estimate of $1.20, compares with $1.13 in Q3 and $1.16 in the year-ago quarter.
    • Reflects growth in loans and deposits; credit performance remained strong, says CFO John Shrewsberry. Effective income tax rate was lower vs. Q3.
    • Wells Fargo slips 1.2% in premarket trading.
    • "We continued to have positive business trends in the fourth quarter with primary consumer checking customers, consumer credit card active accounts, debit and credit card usage, commercial loan balances, and loan originations in auto, small business, home equity and student lending all growing compared with a year ago," Shrewsberry says.
    • Q4 net interest margin of 2.94%, unchanged from Q3, and vs. 2.84% in Q4 2017.
    • Q4 effective income tax rate was 13.7% vs. 20.1% in Q3.
    • Q4 mortgage banking income of $467M fell from $846M in Q3.
    • Total average loans were $946.3B in Q4, up $6.9B form Q3.
    • Total average deposits $1.3T, up $2.6B from Q3.
    • Allowance for credit losses $10.7B at Dec. 31, 2018, down $249M from Sept. 30, 2018.
    • Community Banking net income of $3.17B vs. $2.82B in Q3 and $3.47B in Q4 2017.
    • Wholesale Banking net income was $2.67B vs. $2.85B in Q3 and $2.37B in Q4 2017.
    • Wealth and Investment Management net income of $689M vs. $732M in Q3 and $675M in Q4 2017.
    • Return on equity 12.89% vs. 12.04% in Q3 and 12.47% a year ago.
    • Previously: Wells Fargo beats by $0.01, misses on revenue (Jan. 15)
    | 8:45 AM | 12 Comments
  • Goldman likes Incyte in premarket analyst action

    • Array BioPharma (NASDAQ:ARRY) initiated with Overweight rating and $30 (76% upside) price target. Shares are up 9% premarket on late-stage Mektovi/Braftovi data.
    • Incyte (NASDAQ:INCY) added to Conviction List with a $111 (51% upside) price target at Goldman Sachs citing M&A possibilities. Shares up 3% premarket.
    • MEDNAX (NYSE:MD) upgraded to Buy at Citigroup.
    • Medtronic (NYSE:MDT) upgraded to Buy with a $100 (18% upside) price target at BTIG Research. Shares up 1% premarket.
    | 8:38 AM | Comments
  • Oracle -1% on Morgan Stanley downgrade

    • Oracle (NYSE:ORCL) drops 1.1% premarket after Morgan Stanley downgrades the company from Overweight to Equal-Weight citing a lack of catalysts.
    • Oracle has 16 Buy-equivalent analyst ratings, 20 Holds, and one each of Underperform and Sell. The average price target is $52.45.
    | 8:31 AM
  • Apricus Biosciences to merge with Seelos Therapeutics; shares up 6% premarket

    • Apricus Biosciences (NASDAQ:APRI) is up 6% on signing merger agreement with Seelos Therapeutics. Over 95% of the votes cast were in favor of the merger with Seelos and over 85% were in favor of the reverse stock split.
    • Under the terms of agreement, the holders of Seelos’ outstanding capital stock will receive common shares of Apricus upon closing of merger.
    • Seelos and Apricus stockholders are expected to own ~85% and ~15%, respectively of the merged company.
    • Upon closing, current Apricus stockholders will receive one Contingent Value Right (CVR) per share of Apricus common stock owned.
    • The proposed merger is expected to close in January 2019.
    | 8:30 AM | Comments
  • Tenet inks new contract with Humana; shares up 2% premarket

    • Tenet Healthcare (NYSE:THC) is up 2% premarket on light volume on the heels of its new multiyear agreement with Humana (NYSE:HUM) providing in-network access to THC's hospitals, outpatients centers and doctors. The contract will be in effect through May 2023. Financial terms are not disclosed.
    | 8:23 AM
  • Blue Apron +11% after update

    • Blue Apron (APRN -2.8%) tips off some announcements that it will make with earnings on January 31.
    • The company says it plans to reaffirm confidence in achieving profitability on an adjusted EBITDA basis both in the Q1 of 2019 and for the full year 2019 as it actively pursues the appropriate strategies to create value for its stakeholders.
    • Blue Apron also plans to update on product innovations and new consumer engagement strategies.
    • APRN +11.44% premarket to $1.16.
    • Source: Press Release
    | 8:19 AM | Comment
  • Myos Rens up 30% on positive data in study evaluating Fortetropin for muscle atrophy in dogs

    • MYOS RENS Technology (NASDAQ:MYOS) is up 30% on announcing positive top-line results from a study evaluating the impact of Fortetropin on attenuating muscle atrophy following a common surgical procedure known as tibial-plateau leveling osteotomy in 100 dogs.
    • The objective of the study was to determine whether Fortetropin could reduce muscle atrophy.
    • Fortetropin prevented the loss of muscle mass in these dogs and a more significant improvement in percentage of weight supported by the affected limb was observed as compared to the placebo group.
    • Fortetropin also prevented a rise in serum myostatin levels.
    • An oral summary of study results will be presented on January 20, at the North American Veterinary Community/VMX Conference in Orlando, Florida.
    | 8:05 AM
  • Array Bio up 11% premarket on positive late-stage data on triplet therapy for certain type of colorectal cancer

    • Array BioPharma (NASDAQ:ARRY) is up 11% premarket on light volume on the heels of its announcement of updated data from a Phase 3 clinical trial, BEACON CRC, evaluating the combination of BRAFTOVI (encorafenib), MEKTOVI (binimetinib) and Eli Lilly's ERBITUX (cetuximab) in patients with BRAF-V600E-positive metastatic colorectal cancer (CRC). The results will be presented at the ASCO GI Cancers Symposium in San Francisco.
    • Median overall survival (OS) was 15.3 months. Median progression-free survival (PFS) was eight months and the overall response rate (ORR) was 48%.
    • No new safety signals were observed.
    | 7:55 AM | 15 Comments
  • Conrol4 -5% on Raymond James downgrade

    • Raymond James downgrades Control4 (NASDAQ:CTRL) from Outperform to Market Perform. (Source: Bloomberg First Word)
    • The downgrade follows a 28% pullback in the past quarter on tariff risks and soft housing starts.
    • Control4 has 7 Buy-equivalent analyst ratings and 2 Holds with an average price target of $31.75.
    • CTRL is down 5.2% premarket to $18.25.
    | 7:39 AM | Comment
  • ARMOUR Residential -3.1% after stock offering upsized

    | 7:34 AM | 20 Comments
  • McEwen Mining +2% as 2018 production tops guidance

    • McEwen Mining (NYSE:MUX+2.2% pre-market after reporting FY 2018 production exceeded guidance, with gold equiv. output of 175.5K oz. rising 15% Y/Y and beating the company's outlook of 171K oz.
    • Full-year production included 135.1K oz. of gold, up 23% Y/Y, and 3.03M oz. of silver, 4.5% lower than the previous tear.
    • MUX says 2018 production at its 100%-owned Black Fox mine in Canada totaled 48.8K gold equiv. oz., in line with guidance of 48K gold equiv. oz., and output at its 100%-owned El Gallo project in Mexico of 39K gold. equiv. oz. topped guidance of 32K oz.
    • MUX also says construction at the Gold Bar mine in Nevada is near completion and on schedule for inaugural gold production in Q1.
    | 7:32 AM | 14 Comments
  • Box +1.7% as Rosenblatt leaves sidelines

    • Rosenblatt upgrades Box (NYSE:BOX) from Neutral to Buy and raises the target from $25 to $27, a 45% upside to yesterday's close. (Source: Bloomberg First Word)
    • Box shares are down 16% in the past year but made it through last quarter's tech rout down only 1.4% partly due to M&A speculation.
    • Box has 10 Buy-equivalent analyst ratings and 5 Holds with an average price target of $25.77.
    • Box shares are up 1.7% premarket to $18.90.
    | 7:22 AM | Comment
Market Alerts In Real Time
  • EXPIRED - GT Goodyear Tire & Rubber Co's stock price has reached a new 52 week low

    • The New Low signal triggers as soon as a new 52 week low level is reached. This signal could be used to help identify both shorter and longer term trends.
    • Signal issued at: 03:00:50 PM ET. Expires at: 04:00:00 PM ET
    Today, 3:00 PM
  • EXPIRED - NFLX Netflix, Inc is trading below its normal trading range

    • Historically, 79% of the time NFLX's share price has moved back into its normal trading range of $352.98 to $354.18.
    • Signal issued at: 02:29:39 PM ET. Expires at: 02:49:39 PM ET
    Today, 2:29 PM
  • EXPIRED - CELG Celgene Corporation's stock price has reached a new 13 week high

    • The New High signal triggers as soon as a new 13 week high level is reached. This signal could be used to help identify both shorter and longer term trends.
    • Signal issued at: 01:46:54 PM ET. Expires at: 04:00:00 PM ET
    Today, 1:46 PM
  • EXPIRED - GT Goodyear Tire & Rubber Co is trading below its normal trading range

    • Historically, 79% of the time GT's share price has moved back into its normal trading range of $21.08 to $21.14.
    • Signal issued at: 12:32:59 PM ET. Expires at: 12:52:59 PM ET
    Today, 12:32 PM
  • EXPIRED - DAL Delta Air Lines, Inc is trading above its normal trading range

    • Historically, 76% of the time DAL's share price has moved back into its normal trading range of $47.59 to $47.71.
    • Signal issued at: 12:13:01 PM ET. Expires at: 12:33:01 PM ET
    Today, 12:13 PM
  • EXPIRED - ADS Alliance Data Systems Corporation is trading above its normal trading range

    • Historically, 70% of the time ADS's share price has moved back into its normal trading range of $169.73 to $170.15.
    • Signal issued at: 12:06:02 PM ET. Expires at: 12:26:02 PM ET
    Today, 12:06 PM
  • EXPIRED - SYMC Symantec Corporation is trading above its normal trading range

    • Historically, 72% of the time SYMC's share price has moved back into its normal trading range of $19.56 to $19.61.
    • Signal issued at: 12:04:21 PM ET. Expires at: 12:24:21 PM ET
    Today, 12:04 PM
  • EXPIRED - C Citigroup Inc is trading above its normal trading range

    • Historically, 78% of the time C's share price has moved back into its normal trading range of $61.32 to $61.48.
    • Signal issued at: 12:02:59 PM ET. Expires at: 12:22:59 PM ET
    Today, 12:02 PM
  • EXPIRED - GWW W.W. Grainger, Inc is trading above its normal trading range

    • Historically, 73% of the time GWW's share price has moved back into its normal trading range of $290.51 to $291.29.
    • Signal issued at: 12:02:34 PM ET. Expires at: 12:22:34 PM ET
    Today, 12:02 PM
  • EXPIRED - CMG Chipotle Mexican Grill, Inc's stock price has reached a new 13 week high

    • The New High signal triggers as soon as a new 13 week high level is reached. This signal could be used to help identify both shorter and longer term trends.
    • Signal issued at: 11:59:10 AM ET. Expires at: 04:00:00 PM ET
    Today, 11:59 AM
  • EXPIRED - BAC Bank of America Corporation is trading above its normal trading range

    • Historically, 75% of the time BAC's share price has moved back into its normal trading range of $26.41 to $26.48.
    • Signal issued at: 11:58:07 AM ET. Expires at: 12:18:07 PM ET
    Today, 11:58 AM
  • EXPIRED - AFL Aflac Incorporated's stock price has reached a new 13 week high

    • The New High signal triggers as soon as a new 13 week high level is reached. This signal could be used to help identify both shorter and longer term trends.
    • Signal issued at: 11:58:02 AM ET. Expires at: 04:00:00 PM ET
    Today, 11:58 AM
  • EXPIRED - ARNC Arconic Inc is trading above its normal trading range

    • Historically, 70% of the time ARNC's share price has moved back into its normal trading range of $19.29 to $19.42.
    • Signal issued at: 11:25:24 AM ET. Expires at: 11:45:24 AM ET
    Today, 11:25 AM
  • EXPIRED - GT Goodyear Tire & Rubber Co is trading below its normal trading range

    • Historically, 79% of the time GT's share price has moved back into its normal trading range of $21.75 to $21.8.
    • Signal issued at: 11:23:18 AM ET. Expires at: 11:43:18 AM ET
    Today, 11:23 AM
  • EXPIRED - DAL Delta Air Lines, Inc is trading below its normal trading range

    • Historically, 76% of the time DAL's share price has moved back into its normal trading range of $47.61 to $47.73.
    • Signal issued at: 11:07:00 AM ET. Expires at: 11:27:00 AM ET
    Today, 11:07 AM
  • EXPIRED - TTWO Take-Two Interactive Software, Inc is trading below its normal trading range

    • Historically, 71% of the time TTWO's share price has moved back into its normal trading range of $104.0 to $104.28.
    • Signal issued at: 11:06:09 AM ET. Expires at: 11:26:09 AM ET
    Today, 11:06 AM
  • EXPIRED - NKTR Nektar Therapeutics is trading above its normal trading range

    • Historically, 75% of the time NKTR's share price has moved back into its normal trading range of $43.14 to $43.29.
    • Signal issued at: 11:05:01 AM ET. Expires at: 11:25:01 AM ET
    Today, 11:05 AM
  • EXPIRED - QCOM Qualcomm Inc is trading below its normal trading range

    • Historically, 79% of the time QCOM's share price has moved back into its normal trading range of $55.98 to $56.13.
    • Signal issued at: 11:00:19 AM ET. Expires at: 11:20:19 AM ET
    Today, 11:00 AM
  • EXPIRED - C Citigroup Inc is trading above its normal trading range

    • Historically, 78% of the time C's share price has moved back into its normal trading range of $60.57 to $60.72.
    • Signal issued at: 11:00:02 AM ET. Expires at: 11:20:02 AM ET
    Today, 11:00 AM
  • EXPIRED - GWW W.W. Grainger, Inc is trading above its normal trading range

    • Historically, 73% of the time GWW's share price has moved back into its normal trading range of $288.31 to $289.06.
    • Signal issued at: 10:54:22 AM ET. Expires at: 11:14:22 AM ET
    Today, 10:54 AM
  • EXPIRED - INCY Incyte Corporation is trading above its normal trading range

    • Historically, 79% of the time INCY's share price has moved back into its normal trading range of $76.52 to $76.85.
    • Signal issued at: 10:36:23 AM ET. Expires at: 10:56:23 AM ET
    Today, 10:36 AM
  • EXPIRED - INCY Incyte Corporation's stock price has reached a new 26 week high

    • The New High signal triggers as soon as a new 26 week high level is reached. This signal could be used to help identify both shorter and longer term trends.
    • Signal issued at: 10:34:11 AM ET. Expires at: 04:00:00 PM ET
    Today, 10:34 AM
  • EXPIRED - LLY Eli Lilly and Company is trading above its normal trading range

    • Historically, 69% of the time LLY's share price has moved back into its normal trading range of $116.14 to $116.43.
    • Signal issued at: 10:30:02 AM ET. Expires at: 10:50:02 AM ET
    Today, 10:30 AM
  • EXPIRED - WFC Wells Fargo & Co is trading below its normal trading range

    • Historically, 76% of the time WFC's share price has moved back into its normal trading range of $47.39 to $47.51.
    • Signal issued at: 10:22:45 AM ET. Expires at: 10:42:45 AM ET
    Today, 10:22 AM
  • EXPIRED - MU Micron Technology Inc is trading below its normal trading range

    • Historically, 72% of the time MU's share price has moved back into its normal trading range of $34.5 to $34.62.
    • Signal issued at: 10:22:15 AM ET. Expires at: 10:42:15 AM ET
    Today, 10:22 AM
  • EXPIRED - NOC Northrop Grumman Corporation is trading below its normal trading range

    • Historically, 72% of the time NOC's share price has moved back into its normal trading range of $257.29 to $257.97.
    • Signal issued at: 10:15:38 AM ET. Expires at: 10:35:38 AM ET
    Today, 10:15 AM
  • EXPIRED - CPRT Copart, Inc is trading below its normal trading range

    • Historically, 79% of the time CPRT's share price has moved back into its normal trading range of $49.61 to $49.73.
    • Signal issued at: 10:15:36 AM ET. Expires at: 10:35:36 AM ET
    Today, 10:15 AM
  • EXPIRED - IR Ingersoll-Rand plc is trading below its normal trading range

    • Historically, 68% of the time IR's share price has moved back into its normal trading range of $94.34 to $94.59.
    • Signal issued at: 10:15:30 AM ET. Expires at: 10:35:30 AM ET
    Today, 10:15 AM
  • EXPIRED - ETN Eaton Corp. plc is trading below its normal trading range

    • Historically, 77% of the time ETN's share price has moved back into its normal trading range of $69.65 to $69.83.
    • Signal issued at: 10:15:23 AM ET. Expires at: 10:35:23 AM ET
    Today, 10:15 AM
  • EXPIRED - CAT Caterpillar Inc is trading below its normal trading range

    • Historically, 75% of the time CAT's share price has moved back into its normal trading range of $130.84 to $131.28.
    • Signal issued at: 10:15:19 AM ET. Expires at: 10:35:19 AM ET
    Today, 10:15 AM
  • EXPIRED - JCI Johnson Controls International plc is trading below its normal trading range

    • Historically, 73% of the time JCI's share price has moved back into its normal trading range of $31.8 to $31.88.
    • Signal issued at: 10:15:17 AM ET. Expires at: 10:35:17 AM ET
    Today, 10:15 AM
  • EXPIRED - MHK Mohawk Industries Inc is trading below its normal trading range

    • Historically, 72% of the time MHK's share price has moved back into its normal trading range of $122.76 to $123.14.
    • Signal issued at: 10:15:14 AM ET. Expires at: 10:35:14 AM ET
    Today, 10:15 AM
  • EXPIRED - ADSK Autodesk, Inc is trading above its normal trading range

    • Historically, 68% of the time ADSK's share price has moved back into its normal trading range of $135.77 to $136.17.
    • Signal issued at: 10:13:54 AM ET. Expires at: 10:33:54 AM ET
    Today, 10:13 AM
  • EXPIRED - AOS A. O. Smith Corporation is trading below its normal trading range

    • Historically, 68% of the time AOS's share price has moved back into its normal trading range of $45.84 to $45.97.
    • Signal issued at: 10:13:09 AM ET. Expires at: 10:33:09 AM ET
    Today, 10:13 AM
  • EXPIRED - SWK Stanley Black & Decker, Inc is trading below its normal trading range

    • Historically, 67% of the time SWK's share price has moved back into its normal trading range of $128.77 to $129.15.
    • Signal issued at: 10:13:04 AM ET. Expires at: 10:33:04 AM ET
    Today, 10:13 AM
  • EXPIRED - VMC Vulcan Materials Company is trading below its normal trading range

    • Historically, 75% of the time VMC's share price has moved back into its normal trading range of $100.25 to $100.53.
    • Signal issued at: 10:12:54 AM ET. Expires at: 10:32:54 AM ET
    Today, 10:12 AM
  • EXPIRED - MLM Martin Marietta Materials Inc is trading below its normal trading range

    • Historically, 75% of the time MLM's share price has moved back into its normal trading range of $176.23 to $176.69.
    • Signal issued at: 10:11:43 AM ET. Expires at: 10:31:43 AM ET
    Today, 10:11 AM
  • EXPIRED - AVGO Broadcom Limited is trading above its normal trading range

    • Historically, 81% of the time AVGO's share price has moved back into its normal trading range of $258.26 to $258.99.
    • Signal issued at: 10:11:23 AM ET. Expires at: 10:31:23 AM ET
    Today, 10:11 AM
  • EXPIRED - ANTM Anthem, Inc is trading above its normal trading range

    • Historically, 76% of the time ANTM's share price has moved back into its normal trading range of $257.66 to $258.31.
    • Signal issued at: 10:11:04 AM ET. Expires at: 10:31:04 AM ET
    Today, 10:11 AM
  • EXPIRED - DIS The Walt Disney Company is trading below its normal trading range

    • Historically, 75% of the time DIS's share price has moved back into its normal trading range of $111.97 to $112.26.
    • Signal issued at: 10:10:06 AM ET. Expires at: 10:30:06 AM ET
    Today, 10:10 AM
  • EXPIRED - ALXN Alexion Pharmaceuticals, Inc is trading above its normal trading range

    • Historically, 70% of the time ALXN's share price has moved back into its normal trading range of $109.61 to $109.97.
    • Signal issued at: 10:09:15 AM ET. Expires at: 10:29:15 AM ET
    Today, 10:09 AM
  • EXPIRED - BLL Ball Corporation is trading above its normal trading range

    • Historically, 73% of the time BLL's share price has moved back into its normal trading range of $48.87 to $49.0.
    • Signal issued at: 10:09:02 AM ET. Expires at: 10:29:02 AM ET
    Today, 10:09 AM
  • EXPIRED - UNH UnitedHealth Group Inc is trading above its normal trading range

    • Historically, 71% of the time UNH's share price has moved back into its normal trading range of $250.92 to $251.56.
    • Signal issued at: 10:06:57 AM ET. Expires at: 10:26:57 AM ET
    Today, 10:06 AM
  • EXPIRED - NRG NRG Energy, Inc is trading above its normal trading range

    • Historically, 74% of the time NRG's share price has moved back into its normal trading range of $40.25 to $40.35.
    • Signal issued at: 10:06:13 AM ET. Expires at: 10:26:13 AM ET
    Today, 10:06 AM
  • EXPIRED - BMY Bristol-Myers Squibb Company is trading above its normal trading range

    • Historically, 73% of the time BMY's share price has moved back into its normal trading range of $48.56 to $48.69.
    • Signal issued at: 10:05:34 AM ET. Expires at: 10:25:34 AM ET
    Today, 10:05 AM
  • EXPIRED - AVGO Broadcom Limited's stock price has reached a new 26 week high

    • The New High signal triggers as soon as a new 26 week high level is reached. This signal could be used to help identify both shorter and longer term trends.
    • Signal issued at: 10:05:13 AM ET. Expires at: 04:00:00 PM ET
    Today, 10:05 AM
  • EXPIRED - NKTR Nektar Therapeutics is trading above its normal trading range

    • Historically, 75% of the time NKTR's share price has moved back into its normal trading range of $42.4 to $42.64.
    • Signal issued at: 10:02:07 AM ET. Expires at: 10:22:07 AM ET
    Today, 10:02 AM
  • EXPIRED - ANSS ANSYS, Inc is trading above its normal trading range

    • Historically, 77% of the time ANSS's share price has moved back into its normal trading range of $154.79 to $155.23.
    • Signal issued at: 10:02:03 AM ET. Expires at: 10:22:03 AM ET
    Today, 10:02 AM
  • EXPIRED - GOOG Alphabet, Inc. Cl C is trading above its normal trading range

    • Historically, 74% of the time GOOG's share price has moved back into its normal trading range of $1060.4 to $1063.08.
    • Signal issued at: 10:02:01 AM ET. Expires at: 10:22:01 AM ET
    Today, 10:02 AM
  • EXPIRED - NKE Nike Inc is trading above its normal trading range

    • Historically, 73% of the time NKE's share price has moved back into its normal trading range of $76.91 to $77.11.
    • Signal issued at: 10:02:01 AM ET. Expires at: 10:22:01 AM ET
    Today, 10:02 AM
  • EXPIRED - FB Facebook is trading above its normal trading range

    • Historically, 84% of the time FB's share price has moved back into its normal trading range of $148.81 to $149.31.
    • Signal issued at: 10:01:54 AM ET. Expires at: 10:21:54 AM ET
    Today, 10:01 AM
  • EXPIRED - PPL PPL Corporation is trading above its normal trading range

    • Historically, 71% of the time PPL's share price has moved back into its normal trading range of $29.17 to $29.24.
    • Signal issued at: 10:01:39 AM ET. Expires at: 10:21:39 AM ET
    Today, 10:01 AM
  • EXPIRED - OKE ONEOK, Inc is trading above its normal trading range

    • Historically, 82% of the time OKE's share price has moved back into its normal trading range of $60.23 to $60.38.
    • Signal issued at: 10:01:31 AM ET. Expires at: 10:21:31 AM ET
    Today, 10:01 AM
  • EXPIRED - ABT Abbott Laboratories is trading above its normal trading range

    • Historically, 73% of the time ABT's share price has moved back into its normal trading range of $68.95 to $69.12.
    • Signal issued at: 10:01:27 AM ET. Expires at: 10:21:27 AM ET
    Today, 10:01 AM
  • EXPIRED - SYK Stryker Corporation is trading above its normal trading range

    • Historically, 89% of the time SYK's share price has moved back into its normal trading range of $159.25 to $159.66.
    • Signal issued at: 10:01:24 AM ET. Expires at: 10:21:24 AM ET
    Today, 10:01 AM
  • EXPIRED - ISRG Intuitive Surgical, Inc is trading above its normal trading range

    • Historically, 73% of the time ISRG's share price has moved back into its normal trading range of $510.38 to $511.84.
    • Signal issued at: 10:01:15 AM ET. Expires at: 10:21:15 AM ET
    Today, 10:01 AM
  • EXPIRED - ANET Arista Networks, Inc is trading above its normal trading range

    • Historically, 72% of the time ANET's share price has moved back into its normal trading range of $219.0 to $219.63.
    • Signal issued at: 10:00:23 AM ET. Expires at: 10:20:23 AM ET
    Today, 10:00 AM
  • EXPIRED - HCA HCA Holdings, Inc is trading above its normal trading range

    • Historically, 83% of the time HCA's share price has moved back into its normal trading range of $130.53 to $130.86.
    • Signal issued at: 10:00:19 AM ET. Expires at: 10:20:19 AM ET
    Today, 10:00 AM
  • EXPIRED - COO The Cooper Companies Inc is trading above its normal trading range

    • Historically, 79% of the time COO's share price has moved back into its normal trading range of $262.4 to $263.1.
    • Signal issued at: 10:00:15 AM ET. Expires at: 10:20:15 AM ET
    Today, 10:00 AM
  • EXPIRED - AGN Allergan plc is trading above its normal trading range

    • Historically, 73% of the time AGN's share price has moved back into its normal trading range of $150.63 to $151.02.
    • Signal issued at: 10:00:11 AM ET. Expires at: 10:20:11 AM ET
    Today, 10:00 AM
  • EXPIRED - CNP CenterPoint Energy, Inc's stock price has reached a new 52 week high

    • The New High signal triggers as soon as a new 52 week high level is reached. This signal could be used to help identify both shorter and longer term trends.
    • Signal issued at: 09:59:33 AM ET. Expires at: 04:00:00 PM ET
    Today, 9:59 AM
  • EXPIRED - CRM Salesforce.com, Inc's stock price has reached a new 13 week high

    • The New High signal triggers as soon as a new 13 week high level is reached. This signal could be used to help identify both shorter and longer term trends.
    • Signal issued at: 09:44:25 AM ET. Expires at: 04:00:00 PM ET
    Today, 9:44 AM
  • EXPIRED - PYPL PayPal Holdings, Inc's stock price has reached a new 13 week high

    • The New High signal triggers as soon as a new 13 week high level is reached. This signal could be used to help identify both shorter and longer term trends.
    • Signal issued at: 09:36:49 AM ET. Expires at: 04:00:00 PM ET
    Today, 9:36 AM
  • EXPIRED - KEYS Keysight Technologies Inc's stock price has reached a new 13 week high

    • The New High signal triggers as soon as a new 13 week high level is reached. This signal could be used to help identify both shorter and longer term trends.
    • Signal issued at: 09:35:42 AM ET. Expires at: 04:00:00 PM ET
    Today, 9:35 AM
  • EXPIRED - M Macy's Inc's stock price has reached a new 26 week low

    • The New Low signal triggers as soon as a new 26 week low level is reached. This signal could be used to help identify both shorter and longer term trends.
    • Signal issued at: 09:34:32 AM ET. Expires at: 04:00:00 PM ET
    Today, 9:34 AM
  • EXPIRED - DLTR Dollar Tree, Inc's 14 Day RSI broke below the 70 level

    • The Relative Strength Indicator (RSI) is a momentum oscillator that measures the speed and change of price movements.
    • Traditionally when the RSI breaks below the 70 level that is considered a bearish event.
    • Signal issued at: 09:30:43 AM ET. Expires at: 04:00:00 PM ET
    Today, 9:30 AM
  • EXPIRED - PCG PG&E Corporation's stock price has reached a new 52 week low

    • The New Low signal triggers as soon as a new 52 week low level is reached. This signal could be used to help identify both shorter and longer term trends.
    • Signal issued at: 09:30:01 AM ET. Expires at: 04:00:00 PM ET
    Today, 9:30 AM
  • EXPIRED - D Dominion Energy, Inc's stock price has reached a new 26 week low

    • The New Low signal triggers as soon as a new 26 week low level is reached. This signal could be used to help identify both shorter and longer term trends.
    • Signal issued at: 09:30:01 AM ET. Expires at: 04:00:00 PM ET
    Today, 9:30 AM
  • EXPIRED - KEYS Keysight Technologies Inc's stock price has reached a new 13 week high

    • The New High signal triggers as soon as a new 13 week high level is reached. This signal could be used to help identify both shorter and longer term trends.
    • Signal issued at: 01:32:15 PM ET. Expires at: 04:00:00 PM ET
    Yesterday, 1:32 PM
  • EXPIRED - NWL Newell Brands Inc is trading above its normal trading range

    • Historically, 70% of the time NWL's share price has moved back into its normal trading range of $20.43 to $20.48.
    • Signal issued at: 12:10:39 PM ET. Expires at: 12:30:39 PM ET
    Yesterday, 12:10 PM
  • EXPIRED - FE FirstEnergy Corp is trading below its normal trading range

    • Historically, 83% of the time FE's share price has moved back into its normal trading range of $37.59 to $37.68.
    • Signal issued at: 11:47:24 AM ET. Expires at: 12:07:24 PM ET
    Yesterday, 11:47 AM
  • EXPIRED - IPGP IPG Photonics Corporation is trading above its normal trading range

    • Historically, 68% of the time IPGP's share price has moved back into its normal trading range of $126.71 to $127.06.
    • Signal issued at: 11:42:38 AM ET. Expires at: 12:02:38 PM ET
    Yesterday, 11:42 AM
  • EXPIRED - WDC Western Digital Corporation is trading above its normal trading range

    • Historically, 70% of the time WDC's share price has moved back into its normal trading range of $37.18 to $37.3.
    • Signal issued at: 11:37:35 AM ET. Expires at: 11:57:35 AM ET
    Yesterday, 11:37 AM
  • EXPIRED - ED Consolidated Edison Inc's stock price has reached a new 26 week low

    • The New Low signal triggers as soon as a new 26 week low level is reached. This signal could be used to help identify both shorter and longer term trends.
    • Signal issued at: 11:32:38 AM ET. Expires at: 04:00:00 PM ET
    Yesterday, 11:32 AM
  • EXPIRED - LB L Brands, Inc is trading below its normal trading range

    • Historically, 72% of the time LB's share price has moved back into its normal trading range of $26.72 to $26.8.
    • Signal issued at: 11:24:04 AM ET. Expires at: 11:44:04 AM ET
    Yesterday, 11:24 AM
Advertisement